• Theoharides drug interactions
• Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010
• Autism mast cells - BBA 2012
• Autism serum IL-6, TNF, luteolin - Transl Psych 9-2015
• Autism subtype brain allergy - Clin Therapeutics May 2013
• Autism, brain inflammation - J Neuroinflammation 2012
• Autism, high serum CRH, neurotensin, dog model - Transl Psych 2104
• Autism, hippocampus, molecular profiling - medRxiv Oct 2022
• Autism, mastocytosis - Intl J Immunopathol Pharmacol 2009
• Autism, NeuroProtek - Clin Therapeutics May 2013
• Autism, NeuroProtek - IJIP6 2012
• Autism, Perinatal stress - BMC Peds 9-2012
• Mast cells, IL-37 - Intl J Mol Sci 2019
• Neuroinflammation, seizures, autism - J Neuroinflamm 2011
• Neurotensin, autism - PNAS 2016
• Perinatal mast cells, coronavirus, autism - J Pers Med 2021
• Extracellular vesicles are increased in the serum of children with autism spectrum disorder
• Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders
• Extracellular Mitochondrial ATP, Suramin, and Autism?
• Exosomes in Neurologic and Psychiatric Disorders
• Potential Etiologic Factors of Microbiome Disruption in Autism
• Effects of Mycotoxinson Neuropsychiatric Symptoms and Immune Processes
• Autism Drugs in Wealthy Nations
• Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders...
• Focal Brain Inflammation and Autism
• Novel therapeutic targets for autism
• Mast cells as targets of corticotropin releasing factor and related peptides
• Critical role of mast cells in inflammatory diseases and the effect of acute stress
• Autism: an emerging ‘neuroimmune disorder’ in search of therapy
• Autism Spectrum Disorders and Mastocytosis
• Mercury induces inflammatory mediator release from human mast cells
• Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children
• Neurotensin is increased in serum of young children with autistic disorder
• Autism, elevated serum CRH, NT-Transl Psych 2014
• Autism, NeuroProtek Clin Therapeutics May 2013
• Autism, NeuroProtek, IJIP6-2012
• Mast cells, stress, fear, autism, Intl J Mol Sci 2019
• Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010
• Atopic conditions, Clin Therapeutics May 2013
• Autism subtype brain allergy Clin Therapeutics May 2013
• Autism, allergies, JADD 2011
• Atopic Diseases and Inflammation of the brain in the pathogenesis of autism spectrum disorders
• Autism, brain inflammation, J Neuroinflammation 2012
• Brain inflammation, Long-COVID, Cells 2023
• Brain mast cells chapter, Theoharides 2022
• Brain mast cells, Eur J Pharmacol July 2015
• Exosomes, brain, Clin Therap 2014
• Factors affecting neurodevelopment, J Reg Homeost Agents 2019
• Gut Brain Axis and Neuroimmune disorder, Clin Therap May 2015
• Mast cells in meningiomas and brain inflammation 2016
• Mast cells, brain inflammation and autism, Eur J Pharmacol 2016
• Stress, inflammation, Clin Ther 2020
• Stress, inflammation, autoimmunity, Clin Ther May 2020
• Stress, mast cells, Annals Allergy, Asthma Immunol 2020
• Stress, MS Autoimmuni Rev 2013
• Stress, natural treatments, J Reg Hoemost Agents 2019
• The “missing link” in autoimmunity and autism, Autoimm Rev 2013
• Calprotectin, inflammation, COVID-19 - 2022
• COVID-19, mast cells, luteolin highlights
• COVID-19, PAF, microthromboses - 2020
• COVID, mast cells, treatment - 2022
• Spike protein, mast cell, microgia, neuro-COVID Cells - 2023
• Spike proten stimulates mast cells via TLR4
• Spike, coronavirus, long-COVID - 2022
• Brain inflammation, Long-COVID - Cells 2023
• Luteolin, Long-COVID brain fog - Biofactors 2021
• COVID-19 and multisystem inflammatory syndrome
• COVID-19 brain inflammation and autism spectrum disorder
• COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
• COVID-19, microthromboses, inflammation, and platelet activating factor
• Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue
• Luteolin supplements: All that glitters is not gold
• Potential association of mast cells with coronavirus disease 2019
• Be aware of SARS-CoV-2 spike protein: There is more than meets the eye
• Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus
• Luteolin Isolated from Juncus acutus L., a Potential Remedy for Human Coronavirus 229E
• Luteolin is a potential inhibitor of COVID-19: An in silico analysis
• Covid-19, Mast Cells, Lueolin Highlights
• Mast Cell Activation Beyond Histamine And Tryptase - exp Rev Clin Immunol 2023
• Mast Cells, Microglia - neuro-covid cells 2023
• Sars-CoC-2 Spike Protein Mast Cells - ijms, 2023
• Sars-CoV-2 Spike Protein, Microglia - mol Neurobiol 2023
• Sars‐CoV‐2 Spike Protein And Paf - biofactors 2022
• Spike Protein, Mast Cell, Microgia, Neuro-covid cells 2023
• Spike, Coronavirus, Long-covid - mol Neurobiol-nature 2002
• Covid Treatment, Mast Cells - intl J Inf Dis 2022
• Luteolin supplements- All that glitters is not gold - Biofactors 2020
• Luteolin - Neuropsychiatric Disorders
• Luteolin, COVID-19, mast cells, cytokines - BioFactors 2020
• Luteolin, Long-COVID brain fog - Biofactors 2021
• Luteolin, MS - J Neuroinflamm 2009
• Methlut lotion - Intl J Immunpath Pharm 2017
• Methoxyluteolin, mast cells - JACI 2015
• Methoxyluteolin, mast cells - mTOR, JPET 2017
• Autism, elevated serum CRH, NT-Transl Psych 2014
• Autism, NeuroProtek Clin Therapeutics May 2013
• Autism, NeuroProtek, IJIP6-2012
• Mast cells, stress, fear, autism, Intl J Mol Sci 2019
• Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010
• CFS , flavones J Neuroinflamm 2014
• Mast cells, COVID-19_Annals Allergy Asthma 2021
• Luteolin is a potential inhibitor of COVID-19
• Podcast: Mast Cell Matters: Deep dives on MCAS
• Mast Cell Over-Activation, and How it Affects our Mind and Body Well-Being
(Passcode: q*bwPX3M)
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
• Mast cells, Pancreatitis_2014
• Mast cell activation and microbiome
• Mast cell activation beyond histamine and tryptase Exp-Rev-Clin-Immunol_2023
• Mast cell activation disorders, Exp Rev Clin Immunol 2014
• Mast cell mediator disorder, Exp Rev Clin Imminol 2019
• Mast cell, obesity asthma, Allergy 2014
• Mast cells and COVID-19_medRxiv_2022
• Mast cells and SARS-CoV-2_NEJM, 2023
• Mast cells in allergy inflamm Curr Pharm Des 2012
• Mast cells brain inflammation and autism Eur J Pharmacol 2016
• Mast cells, COVID-19_Annals Allergy Asthma 2021
• Mast cells, dendritic cells_JACI 2021
• Mast cells, fear, autism, Intl J Mol Sci 2019
• Mast cells, FMS, pain, Front Cell Neurosci 2019
• Mast cells, IBS, Dig Dis Sc 2014
• Mast cells, IL-1 beta, PNAS 9-2018
• Mast cells, IL-37, Intl J Mol Sci, 2019
• Mast cells, Immunity_IJMS 2023
• Mast cells, inflammation, BBA 2012
• Mast cells, mastocytosis and supplemental, NEJM July 9, 2015
• Mast cells, meningiomas_J Neuroinflam, 2015
• Mast cells, migraines_Brain Res Rev, 2005
• Mast cells, MS, strress, Autoimm Rev, 2013
• Mast cells, neuroinflammation_Front Cell Neurosc, 2019
• Mast cells, neuron contacts, Clin Ther 2016 main
• Mast cells, obesity, MI, Trends Pharm Sc 2011
• Mast cells, pancreatic cancer_NEJM, 2008
• Mast cells, stress, asthma Ann Allergy Asthma Immunol 2012
• Mast cells, stress, fear, autism, Intl J Mol Sci 2019
• Mast cells, stress, heart, Ann Allergy Asthma Immunol 2014
LEGAL DISCLAIMER:
The contents of this website and any provided materials, research, or communications are for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.